# Oxaliplatin

NDC: 72603-301
Generic name: Oxaliplatin
Labeler / Manufacturer: NorthStar Rx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190617
Marketing ended: 20270331
FDA application: ANDA207325

## Active ingredients

- OXALIPLATIN: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-301"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-301
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f299b2d2-86ed-4fb8-822e-65455a0bb75a